Exhaustive Extractions

At iuvo, we work hard to stay on the cutting edge of new developments in testing and regulatory changes affecting the medical device and pharmaceutical industries. We will share these updates regularly here in our blog - Exhaustive Extractions.


iuvo Partners to Support Regional Coronavirus Testing

September 18, 2020 – iuvo BioScience is one of two local companies partnering with Rochester Regional Health to assist with the increasing demand for coronavirus testing. There has been a shortage of Transport Media, so iuvo teamed up with the healthcare provider to produce this essential part of the test kit. “The local ecosystem that […]

FDA Issues Guidance Document on Use of ISO 10993-1

September 8, 2020 – The FDA issued a guidance document on September 4, 2020, on Use of International Standard ISO 10993-1, “Biological Evaluation of Medical Devices – Part 1: Evaluation and testing within a risk management process”.  This document is available on the FDA’s website here. This guidance document, which supersedes the 2016 version of […]

Biocompatibility for UR Biomedical Engineers

March 8, 2020 – iuvo’s Dr. Mary Richardson and Dr. Kathleen Krenzer, members of iuvo’s Lumino Advisors Consulting Group, guest-taught a class on biocompatibility to a group of biomedical engineers on Friday, March 6. The class was a graduate level class taught by Dr. Greg Gdowski at the University of Rochester’s Department of Biomedical Engineering, […]

Chemical Characterization Standard ISO 10993-18:2020 Publishes

January 19, 2020 – The updated version of ISO 10993-18, the standard covering the chemical characterization of the ISO 10993 biocompatibility standard for medical devices, has just published. The new version is available here. The ISO 10993 series applies to devices where the material or medical device has direct or indirect body contact, with ISO 10993-1 […]

iuvo Giving Back for the Holidays

December 18, 2019 – In the spirit of giving back to those a little less financially fortunate,  the iuvo BioScience Community Outreach Team adopted two families in need to help make their holidays a little bit better.   This is the third year in a row that iuvo has participated in the program. The parents provided […]

Oculos Partner Ocuphire Pharma Announces Completion of the First of Two Phase 2b Clinical Trials

RUSH, NY – September 5, 2019 – Ocuphire Pharma, Inc., a clinical-stage pharmaceutical company and partner of iuvo BioScience’s ophthalmic-focused Oculos Division, announced that it has successfully enrolled 39 glaucoma patients in ORION-1 at 5 U.S. sites from late May to August 2019.  Ocuphire has been collaborating closely with Oculos Development Services to achieve these clinical […]

Podcast: iuvo CEO Ben Burton on the Legal Drugs Podcast

September 3, 2019 – iuvo CEO Ben Burton was interviewed on the Legal Drugs Podcast in the most recent episode (episode 5) which became available September 2. The interview took place at the 2019 Society of Toxicology meeting, and provided an opportunity for Ben to speak with Legal Drugs Podcast host Angela Stoyanovitch on testing […]

iuvo Participates in Rochester Day of Caring Spring Clean Up

May 10, 2019 – Ten iuvo employees volunteered at an Epilepsy Pralid Individualized Residential Alternative (IRA) home yesterday as part of the Rochester Day of Caring event. This was our first year participating in the event and we were able to spruce up the outdoors for spring by mulching, planting, weeding, and doing some general […]